Osaic Holdings’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33.8K Buy
45,200
+15,200
+51% +$8.63K ﹤0.01% 5789
2026
Q2
$26.4K Buy
+30,000
New +$31.8K ﹤0.01% 5949
2026
Q1
– Sell
-17
Closed -$13 – 8006
2025
Q4
$13 Hold
17
– – ﹤0.01% 7755
2025
Q3
$17 Sell
17
-500
-97% -$588 ﹤0.01% 7840
2025
Q2
$688 Buy
517
+17
+3% +$23 ﹤0.01% 7279
2025
Q1
$595 Sell
500
-5,017
-91% -$7.14K ﹤0.01% 6956
2024
Q4
$8.99K Buy
5,517
+250
+5% +$662 ﹤0.01% 5864
2024
Q3
$20.1K Hold
5,267
– – ﹤0.01% 5380
2024
Q2
$15.4K Buy
5,267
+17
+0.3% +$54 ﹤0.01% 5518
2024
Q1
$20.8K Buy
5,250
+5,000
+2,000% +$25.8K ﹤0.01% 5343
2023
Q4
$1.24K Sell
250
-6,000
-96% -$29.8K ﹤0.01% 6676
2023
Q3
$31.6K Buy
6,250
+4,250
+213% +$23.3K ﹤0.01% 5289
2023
Q2
$10.1K Sell
2,000
-500
-20% -$3.27K ﹤0.01% 5957
2023
Q1
$15.4K Buy
2,500
+1,498
+150% +$12.3K ﹤0.01% 5722
2022
Q4
$13K Buy
1,002
+2
+0.2% +$14 ﹤0.01% 5817
2022
Q3
$3K Sell
1,000
-11
-1% -$47 ﹤0.01% 6650
2022
Q2
$4K Sell
1,011
-120
-11% -$571 ﹤0.01% 6614
2022
Q1
$7K Sell
1,131
-250
-18% -$1.55K ﹤0.01% 6338
2021
Q4
$11K Sell
1,381
-250
-15% -$2.69K ﹤0.01% 6190
2021
Q3
$25K Sell
1,631
-880
-35% -$11K ﹤0.01% 5618
2021
Q2
$32K Buy
2,511
+1,000
+66% +$7.81K ﹤0.01% 5370
2021
Q1
$7K Buy
1,511
+700
+86% +$2.82K ﹤0.01% 6035
2020
Q4
$2K Hold
811
– – ﹤0.01% 6089
2020
Q3
$2K Buy
811
+800
+7,273% +$2.24K ﹤0.01% 5882
2020
Q2
$0 Hold
11
– – ﹤0.01% 6272
2020
Q1
$0 Buy
+11
New +$19 ﹤0.01% 6149

Other funds holding PDSB

Osaic Holdings's PDSB Position: Q3 2026 in Review

Osaic Holdings increased its PDS Biotechnology (PDSB) stake by 51% in Q3 2026, buying an estimated $8.63K and bringing the position to 45,200 shares worth $33.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5789.

Osaic Holdings first reported a position in PDSB in Q1 2020 and has held it in 26 quarters since. 38 funds tracked by Wall St. Rank hold PDSB as of Q3 2026.

  • Osaic Holdings held 45,200 shares of PDS Biotechnology worth $33.8K as of Q3 2026.
  • Osaic Holdings bought 15,200 PDS Biotechnology shares in Q3 2026, an estimated $8.63K.
  • PDS Biotechnology made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #5789 holding.
  • Osaic Holdings first reported a position in PDS Biotechnology in Q1 2020 and has held it in 26 quarters since.
  • 38 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.